Exosomal miR-136-5p Derived from Anlotinib-Resistant NSCLC Cells Confers Anlotinib Resistance in Non-Small Cell Lung Cancer Through Targeting PPP2R2A

BACKGROUND: Anlotinib resistance is a challenge for advanced non-small cell lung cancer (NSCLC). Understanding the underlying mechanisms against anlotinib resistance is of great importance to improve prognosis and treatment of patients with advanced NSCLC. METHODS: RT-qPCR assay was used to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Guoqing, Hu, Chenxi, Hui, Kaiyuan, Zhang, Huiqin, Chen, Ting, Zhang, Xin, Jiang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455141/
https://www.ncbi.nlm.nih.gov/pubmed/34556984
http://dx.doi.org/10.2147/IJN.S321720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455141/
https://www.ncbi.nlm.nih.gov/pubmed/34556984
http://dx.doi.org/10.2147/IJN.S321720

Ejemplares similares